4) Dr. Patterson is indeed analyzing the samples (

Quote:

---

4) Dr. Patterson is indeed analyzing the samples (or at least some). However, I noticed a little reticence of NP to let it be know that we where completely dependent on analysis from IncellRx. I took this as an indication that this might be taken the wrong way as Dr. Patterson has been very outspoken in supporting CYDY in several interviews. This explains why he has gone silent in the last weeks while analyzing the trial blood samples (from which he must have a good idea of what to expect.)

---

I was wondering this as well and it's obviously noticeable to many of us who really appreciate Dr. BP on the calls. I was wondering if someone may have suggested to NP that it is important for us to appear more independent of our diagnostics company especially the idea that they can test for CCR5 occupancy, effectively unblinding the blinded trial (if you notice, more than ever NP is continually stressing that the data is blinded and we don't know what it is)? I miss Dr. BP being on the calls and NP was heaping SO much praise on him at the beginning of COVID so I wouldn't jump to the conclusion that it is negative but the strategy now seems to downplay the paper and the diagnostics. He did say "he was great" but definitely a more muted vibe.

Quote:

---

7) Three more papers coming. This is very good and supportive. Would like to hear what is happening with Dr. Patterson's one.

---

Again, downplayed on the call as he said we have "lots of papers", but I too am anxiously awaiting *the* paper!

Or perhaps this is all just to give shine to the other supporting entities before Dr. BP is all over the news for his role in discovering COVID19 is a RANTES disease.

When it comes down to it, I think I just need to accept that everything is moving so rapidly behind the scenes that decisions such as our 51 patient interim analysis and/or our NYSE uplist are changing on a daily basis as we have more information/data and are approached by more investment banks/billionaires/big pharma/partners. Looking forward to seeing how everything plays out in the coming weeks...I think the more cautious tones are indicative that things are definitely happening.